Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
32 Upcoming Dividend Increases Including 2 Dividend Kings
04:57pm, Thursday, 02'nd Mar 2023
All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8.3% and a median increase of 8.1%.
LeMaitre Vascular, Inc. (LMAT) Q4 2022 Earnings Call Transcript
12:43pm, Sunday, 26'th Feb 2023
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief
LeMaitre Vascular (LMAT) Q4 Earnings and Revenues Lag Estimates
06:49pm, Thursday, 23'rd Feb 2023
LeMaitre (LMAT) delivered earnings and revenue surprises of -3.85% and 0.57%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ZBH vs. LMAT: Which Stock Is the Better Value Option?
12:47pm, Monday, 20'th Feb 2023
ZBH vs. LMAT: Which Stock Is the Better Value Option?
VREX vs. LMAT: Which Stock Is the Better Value Option?
12:47pm, Tuesday, 24'th Jan 2023
VREX vs. LMAT: Which Stock Is the Better Value Option?
Is This Small-Cap Dividend Stock a Buy?
09:53am, Friday, 13'th Jan 2023
LeMaitre Vascular isn't well-known to investors. But vascular surgeons do know the company well.
ESLOY vs. LMAT: Which Stock Should Value Investors Buy Now?
12:48pm, Friday, 06'th Jan 2023
ESLOY vs. LMAT: Which Stock Is the Better Value Option?
ESLOY or LMAT: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 21'st Dec 2022
ESLOY vs. LMAT: Which Stock Is the Better Value Option?
ESLOY vs. LMAT: Which Stock Is the Better Value Option?
12:48pm, Monday, 05'th Dec 2022
ESLOY vs. LMAT: Which Stock Is the Better Value Option?
LeMaitre: Balance Sheet Ready To Unlock Risk Capital, Reaffirm Buy
01:09am, Thursday, 01'st Dec 2022
Missed top line estimates secondary to FX headwinds and market challenges. Balance sheet remains healthy with adequate cash to deploy for acquisitions, sales rep investments.
Is This Underfollowed Dividend Stock a Buy?
06:05am, Wednesday, 23'rd Nov 2022
The medical device maker flies under the radar of most investors.
LeMaitre to Present at Upcoming Investor Conferences
09:31am, Tuesday, 22'nd Nov 2022
BURLINGTON, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.
LeMaitre to Present at Upcoming Investor Conferences
04:28pm, Wednesday, 02'nd Nov 2022
BURLINGTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.
LeMaitre Vascular (LMAT) Misses Q3 Earnings and Revenue Estimates
08:19pm, Thursday, 27'th Oct 2022
LeMaitre (LMAT) delivered earnings and revenue surprises of -10.71% and 2.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre Vascular, Inc. (LMAT) Q3 2022 Earnings Call Transcript
08:06pm, Thursday, 27'th Oct 2022
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q3 2022 Results Conference Call October 27, 2022 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer David Roberts - President Conference C
